PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Researchers reveal people with Parkinson’s more likely to experience delirium in hospital

Two out of three people with the neurodegenerative condition experienced delirium in hospital.

Researchers from Newcastle University have revealed that people living with Parkinson’s disease (PD) are more likely to experience delirium while in hospital, resulting in confused thinking and a lack of awareness.

Results from the study funded by Parkinson’s UK could lead to better awareness of delirium and improve current tests used to determine delirium in patients with PD.

Considered a serious but treatable condition, delirium can cause confusion and hallucinations, as well as difficulty following conversations and feeling unusually sleepy.

Symptoms of delirium are also symptoms of PD, a neurodegenerative disease that affects around 153,000 people in the UK, which can make delirium difficult to treat in PD patients.

Researchers followed 121 patients with PD and 199 older adults without PD who had a stay in the hospital and documented how many of these patients’ experienced delirium during their time in the hospital and how they progressed over the following 12 months.

They found that two out of three people with PD experienced delirium during their hospital stay, while only one out of three older adults without PD experienced delirium.

Additionally, PD patients who had delirium were ten times more likely to need professional assistance compared to people who did not have delirium.

PD patients who experienced delirium in the hospital were also found to be more likely to have memory and thinking problems, including dementia, 12 months after leaving the hospital.

Despite not knowing why PD patients have an increased risk of experiencing delirium, researchers suggest that the current tests available to determine whether or not someone is experiencing delirium, are not always suitable for PD patients.

Dr Becky Jones, research communications manager, Parkinson’s UK, commented: “This study highlights the urgent need for better ways of measuring delirium in people with PD and being able to treat it sooner.

“Better tests to define and monitor delirium that take into account symptoms of PD could potentially help avoid these adverse effects.”

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026